Breaking News: Oral Wegovy Pill Approved (December 2025) On December 22, 2025 , the FDA approved a pill version of Wegovy , marking a significant milestone as the first daily oral medication for obesity
Here are three evidence-based electrolyte protocols designed specifically for people on GLP-1 medications, ranging from minimal intervention to comprehensive coverage
Many women in our communitywhether youre in Kingwood or The Woodlandsface these challenges, especially when using GLP-1 therapies like semaglutide
Mater Interface 10 (13), 1060110606
Vitamin B12 supports red blood cell production, energy metabolism, and neurological function
Stopping GLP-1 weight-loss drugs triggers sharp metabolic rebound, study warns The largest analysis yet shows why coming off popular obesity and diabetes drugs may undo hard-won gains